These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 36048966

  • 1. Solasonine alleviates high glucose-induced podocyte injury through increasing Nrf2-medicated inhibition of NLRP3 activation.
    Zhang Q, Hu Y, Hu JE, Zhang M.
    Drug Dev Res; 2022 Nov; 83(7):1697-1706. PubMed ID: 36048966
    [Abstract] [Full Text] [Related]

  • 2. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
    Lv C, Cheng T, Zhang B, Sun K, Lu K.
    Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748
    [Abstract] [Full Text] [Related]

  • 3. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-κB/NLRP3 Axis.
    He J, Cui J, Shi Y, Wang T, Xin J, Li Y, Shan X, Zhu Z, Gao Y.
    J Diabetes Res; 2023 Dec; 2023():7423661. PubMed ID: 37261217
    [Abstract] [Full Text] [Related]

  • 4. Sulfiredoxin-1 alleviates high glucose-induced podocyte injury though promoting Nrf2/ARE signaling via inactivation of GSK-3β.
    Shen Y, Chen S, Zhao Y.
    Biochem Biophys Res Commun; 2019 Sep 03; 516(4):1137-1144. PubMed ID: 31284950
    [Abstract] [Full Text] [Related]

  • 5. Perilipin 5 ameliorates high-glucose-induced podocyte injury via Akt/GSK-3β/Nrf2-mediated suppression of apoptosis, oxidative stress, and inflammation.
    Feng J, Xie L, Yu X, Liu C, Dong H, Lu W, Kong R.
    Biochem Biophys Res Commun; 2021 Mar 12; 544():22-30. PubMed ID: 33516878
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M, Yang Z, Zhang C, Shi Y, Han W, Song S, Mu L, Du C, Shi Y.
    Metabolism; 2021 May 12; 118():154748. PubMed ID: 33675822
    [Abstract] [Full Text] [Related]

  • 7. ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.
    Gao Y, Ma Y, Xie D, Jiang H.
    Int Immunopharmacol; 2022 Jun 12; 107():108711. PubMed ID: 35338958
    [Abstract] [Full Text] [Related]

  • 8. FOXM1-activated SIRT4 inhibits NF-κB signaling and NLRP3 inflammasome to alleviate kidney injury and podocyte pyroptosis in diabetic nephropathy.
    Xu X, Zhang L, Hua F, Zhang C, Zhang C, Mi X, Qin N, Wang J, Zhu A, Qin Z, Zhou F.
    Exp Cell Res; 2021 Nov 15; 408(2):112863. PubMed ID: 34626587
    [Abstract] [Full Text] [Related]

  • 9. Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy.
    Sun L, Ding M, Chen F, Zhu D, Xie X.
    PeerJ; 2023 Nov 15; 11():e14826. PubMed ID: 36815984
    [Abstract] [Full Text] [Related]

  • 10. STING deletion alleviates podocyte injury through suppressing inflammation by targeting NLRP3 in diabetic kidney disease.
    Yang X, Chen Z, Luo Z, Yang D, Hao Y, Hu J, Feng J, Zhu Z, Luo Q, Zhang Z, Liang W, Ding G.
    Cell Signal; 2023 Sep 15; 109():110777. PubMed ID: 37329999
    [Abstract] [Full Text] [Related]

  • 11. TRIM32 Inhibition Attenuates Apoptosis, Oxidative Stress, and Inflammatory Injury in Podocytes Induced by High Glucose by Modulating the Akt/GSK-3β/Nrf2 Pathway.
    Chen Z, Tian L, Wang L, Ma X, Lei F, Chen X, Fu R.
    Inflammation; 2022 Jun 15; 45(3):992-1006. PubMed ID: 34783942
    [Abstract] [Full Text] [Related]

  • 12. Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes.
    Xing L, Guo H, Meng S, Zhu B, Fang J, Huang J, Chen J, Wang Y, Wang L, Yao X, Wang H.
    Biochem Biophys Res Commun; 2021 Jan 01; 534():450-456. PubMed ID: 33256980
    [Abstract] [Full Text] [Related]

  • 13. TRIM29 promotes podocyte pyroptosis in diabetic nephropathy through the NF-kB/NLRP3 inflammasome pathway.
    Xu X, Qin Z, Zhang C, Mi X, Zhang C, Zhou F, Wang J, Zhang L, Hua F.
    Cell Biol Int; 2023 Jun 01; 47(6):1126-1135. PubMed ID: 36841942
    [Abstract] [Full Text] [Related]

  • 14. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy.
    Cheng Q, Pan J, Zhou ZL, Yin F, Xie HY, Chen PP, Li JY, Zheng PQ, Zhou L, Zhang W, Liu J, Lu LM.
    Acta Pharmacol Sin; 2021 Jun 01; 42(6):954-963. PubMed ID: 32968210
    [Abstract] [Full Text] [Related]

  • 15. BRD4 contributes to high-glucose-induced podocyte injury by modulating Keap1/Nrf2/ARE signaling.
    Zuo H, Wang S, Feng J, Liu X.
    Biochimie; 2019 Oct 01; 165():100-107. PubMed ID: 31325480
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Knockdown of TLR4 attenuates high glucose-induced podocyte injury via the NALP3/ASC/Caspase-1 signaling pathway.
    Liu Y, Xu Z, Ma F, Jia Y, Wang G.
    Biomed Pharmacother; 2018 Nov 01; 107():1393-1401. PubMed ID: 30257355
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.